InfectoGnostics researchers contributed in form of oral presentations in the program section on diagnostics. In the session "Diagnostics in AMR: Focus on market needs & learnings from COVID-19 innovations", Dr. Stefanie Deinhardt-Emmer from the Jena University Hospital (JUH) used the example of the pandemic virus to illustrate how important it is to address systemic diseases with systemic diagnostics as well. In her research, the senior physician from Jena had discovered that SARS-CoV-2, unlike other viruses, is detectable in many different types of tissue. Diagnostics that would be limited to the respiratory tract alone could thus miss important insights into the course of the disease.
Meanwhile, in the "Diagnostic programs" session, supported by the Foundation for new innovative diagnostics (FIND), Dr. Christian Brandt from the startup "nanozoo" and JUH presented genome analysis services, which are designed to make the complex processing of sequencing data easier for scientists and usable for scientific questions in infection diagnostics with "one click".
In the concluding plenary discussion "Cooperation as new normal? New cooperation models - from early stage to clinical development", InfectoGnostics BoD speaker Prof. Juergen Popp presented the public-private partnership model of InfectoGnostics Reserachg Campus to accelerate the market maturity of innovations. At the same time, he gave an outlook on new cooperation opportunities at the Leibniz Center for Photonics in Infection Research, which has recently started its setup phase.
In addition, scientists from the Leibniz Institute of Photonic Technologies also presented their research contributions in the field of optical-molecular diagnostics and systems technology in the poster sessions.
The Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz-HKI), another member of the research campus, was active with contributions to developments in microfluidics and in particular through its involvement in the INCATE initiative. The campus partners in Basel were also supported by the Thuringian Cluster Management of the State Development Corporation of Thuringia (LEG) and the nationwide Leibniz Health Technologies Research Alliance.
In addition to these many partners from Thuringia, campus partner Autoimmundiagnostika GmbH (AID) from Straßberg (Baden-Wuerttemberg) was also represented at the IOnfectoGnostics booth. The company offers solutions AMR diagnostics and in particular for the diagnosis of tuberculosis, one of the main topics of the One Health section at the AMR Conference.
In addition to scientific exchange, the AMR Conference focuses on research transfer and provides an interface with SMEs and large companies across Europe (BEAM Alliance) as well as global initiatives such as CARB-X. The meeting was attended by over 330 participants from 27 countries.